"Is there also a looming partnership between Merck and Marty Schmemag who did PRECLINICAL studies on some mice in his basement?
Inovio was born on the Vancouver exchange as Concord Energy when energy stocks were hot. It became United Safety Technology when tech stocks were hot. It morphed into Genetronics Biomedical when biotechs were hot. After a dozen name changes, Inovio is still peddling its electropration "technology" which failed in trials in 1997 and failed again this year by licensee ChromTech.
It's time to put this one to bed or twelve feet under. Enough moms and pops have lost their savings on this Pump and Dump Vancouver creation, as the stock has cratered from $50. Nearly 250 million fully diluted shares outstanding after a 1 for 4 reverse split portends a trip back to PennyLand when this coordinated Pump & Dump fizzles and fades.
In 30 years Inovio has not been able to advance anything to a Phase 3 trial. Hey, Marty Schmegag has a better chance of partnering with Merck."
Same old 30 year bullsh. You gotta have somthing better than that. There are many companies who use an old shell of a public company to raise cash and sometimes it takes 30 years before the right management and science get together to get a novel product or platform.